Literature DB >> 8882409

Discrimination of HLA-B27 alleles by group-specific amplification followed by solid-phase sequencing.

R Blasczyk1, M Weber, A van Lessen, N Schwella, D Huhn, A Salama.   

Abstract

HLA-B27 is known to be highly associated with ankylosing spondylitis. Until now, nine B27 subtypes have been sequenced and may contribute in different fashions to ankylosing spondylitis. Additionally, the divergent subtypes may be of clinical importance in bone marrow transplantation with alternative donors. The purpose of this study was to determine the different subtypes of HLA-B27 by a direct sequencing approach. The typing strategy is based on a group-specific amplification of the second and third exon followed by automated fluorescence sequencing of the polymorphic regions. The extensive sharing of sequence motifs between the different B alleles made it impossible to specifically amplify the B27 group under the precondition of including all sequence variations necessary for a postamplification specificity step. Therefore, for setting up a direct sequencing approach of B27, co-amplified B alleles had to be taken into account. In order to get unambiguous sequencing chromatograms without any heterozygous positions, nested sequencing primers were used which selectively matched sequence motifs only present in the second and third exon of the amplified B27 alleles. This strategy allowed in all cases investigated a clear separation of the haplotypes, revealing unequivocal sequencing results. Using this method, we have investigated 93 B27-positive individuals. Sequencing identified the alleles B*2702, 2703, 2704, 2705, and 2707. B*2701, 2706, 2708, and 2709 were not represented in the population studied.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8882409     DOI: 10.1016/0198-8859(95)00147-6

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  2 in total

1.  HLA-B27 detection - comparison of genetic sequence-based method and flow cytometry assay.

Authors:  Urszula Skalska; Anna Kozakiewicz; Włodzimierz Maśliński; Monika Jurkowska
Journal:  Reumatologia       Date:  2015-05-18

2.  Cervus and cucumis peptides combined umbilical cord mesenchymal stem cells therapy for rheumatoid arthritis.

Authors:  Tao Qi; Hongxiang Gao; Yazheng Dang; Shigao Huang; Minfei Peng
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.